SCHEMBL2842973

SCHEMBL2842973

CCN1Cc2cc(C)sc2C(Oc2ccc(C(N)=O)cc2Cl)C1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TPH1 P17752 1/20 0.34
OPRK1 P41145 7/20 0.34
OPRM1 P35372 5/20 0.34
KCNH2 Q12809 3/20 0.34
SLC6A4 P31645 3/20 0.33
SLC6A2 P23975 2/20 0.33
SLC6A3 Q01959 2/20 0.33
OPRD1 P41143 4/20 0.33
MAPK1 P28482 1/20 0.32
TAS1R3 Q7RTX0 1/20 0.32
TAS1R1 Q7RTX1 1/20 0.32
LMNA P02545 1/20 0.32
HTT P42858 1/20 0.32
UTS2R Q9UKP6 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
DUSP3 P51452 1/20 0.31
PTPN5 P54829 1/20 0.31
PTPN11 Q06124 1/20 0.31
INSR P06213 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2839392 0.87 ALDH1A1 (0.34) TPH1OPRK1OPRM1KCNH2SLC6A4
SCHEMBL2839057 0.82 TPH1 (0.37) TPH1OPRK1OPRM1KCNH2OPRD1
SCHEMBL2836972 0.80 SLC6A4 (0.34) OPRK1OPRM1KCNH2SLC6A4SLC6A2
SCHEMBL2844559 0.78 OPRD1 (0.37) TPH1SLC6A4SLC6A2SLC6A3OPRD1
SCHEMBL2841128 0.78 TOP2A (0.36) TPH1OPRK1OPRM1KCNH2SLC6A4
SCHEMBL2838043 0.75 SLC6A2 (0.35) OPRK1KCNH2SLC6A4SLC6A2SLC6A3
SCHEMBL2844273 0.73 ALDH1A1 (0.31) LMNAALDH1A1
SCHEMBL2840993 0.73 OPRD1 (0.36) TPH1OPRK1OPRM1KCNH2OPRD1
SCHEMBL2845541 0.72 MEN1 (0.37) SLC6A4SLC6A2SLC6A3HTR2A
SCHEMBL2835987 0.71 TPH1 (0.38) TPH1OPRK1OPRM1KCNH2OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 TPH1 17/4885OPRK1 3/4885OPRM1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.